UnknownNCT00452231
RCT of CBT Combined With D-Cycloserine for Treating PTSD
Medication studyAges 18–65Canada
Understand this study
Who could participate?
Listed age limits: 18 years to 65 years.
- Listed locations
- MontrealSee all locations and recruitment
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateFebruary 2007
- Recruitment status
- Unknown
- Enrollment listed in the registry
- 20
- Sponsor
- Université de Montréal
- Sponsor type
- University
- Study type
- Behavioral
- Intervention type
- Behavioural, Drug
- Study phase
- Phase 2 / Phase 3This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
- Locations
- Canada
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT00452231
- Official title
Show the full official title
Comparative Study of the Efficacy of a Cognitive-Behavioral Therapy for Post-Traumatic Stress Disorder With or Without D-Cycloserine
Recruitment & locations
Status unknownThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Montreal
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Université de Montréal, a university.
Does this study involve medication?
Yes. The study involves medication, including D-cycloserine.
Who can participate?
Listed age limits: 18 years to 65 years.
